197 related articles for article (PubMed ID: 21936380)
1. [Evaluation of interference of thyroglobulin autoantibodies with assay of thyroglobulin using electrochemiluminescent assay].
Dai Q; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):780-3. PubMed ID: 21936380
[TBL] [Abstract][Full Text] [Related]
2. [Research on comparison of thyroglobulin autoantibody interference in measurement of thyroglobulin between electrochemiluminescent assay and radioimmunoassay].
Dai Q; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):242-6. PubMed ID: 22616166
[TBL] [Abstract][Full Text] [Related]
3. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
4. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
5. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
6. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
Spencer CA; Wang CC
Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
[TBL] [Abstract][Full Text] [Related]
10. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
[TBL] [Abstract][Full Text] [Related]
12. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
[TBL] [Abstract][Full Text] [Related]
13. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Spencer CA
J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
[TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
Persoon AC; Links TP; Wilde J; Sluiter WJ; Wolffenbuttel BH; van den Ouweland JM
Clin Chem; 2006 Jun; 52(6):1196-9. PubMed ID: 16574765
[TBL] [Abstract][Full Text] [Related]
15. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease.
Massart C; Maugendre D
Clin Chem; 2002 Jan; 48(1):102-7. PubMed ID: 11751544
[TBL] [Abstract][Full Text] [Related]
16. Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay.
Gao Y; Yuan Z; Yu Y; Lu H
Clin Biochem; 2007 Jun; 40(9-10):735-8. PubMed ID: 17462616
[TBL] [Abstract][Full Text] [Related]
17. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
Zhang W; Deng H; Pan M; Huang R; Tang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
[TBL] [Abstract][Full Text] [Related]
18. Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer.
Verburg FA; Hartmann D; Grelle I; Giovanella L; Buck AK; Reiners C
Horm Metab Res; 2013 Sep; 45(10):728-35. PubMed ID: 23959452
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.
Spencer CA; Bergoglio LM; Kazarosyan M; Fatemi S; LoPresti JS
J Clin Endocrinol Metab; 2005 Oct; 90(10):5566-75. PubMed ID: 15985472
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
